Oncology Peer Review On-The-Go: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors

Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center

Edward Chu, MD, a member of the gastrointestinal editorial advisory board, died of glioblastoma in November.

Experts from Georgia Cancer Center highlight ongoing retrospective studies, translational research, and other initiatives across different cancers.

Girindra Raval, MD;Amany Keruakous, MD;Daniel Peters, MD

Subcutaneous Toripalimab Meets Primary End Points in Nonsquamous NSCLC

Experts from Georgia Cancer Center highlight ongoing retrospective studies, translational research, and other initiatives across different cancers.

The developers plan to submit a new drug application to regulatory authorities for JS001sc for the treatment of first-line non-squamous NSCLC.

Roman Fabbricatore

November 30th 2025

Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

The developers plan to submit a new drug application to regulatory authorities for JS001sc for the treatment of first-line nonsquamous NSCLC.

Daniel C. McFarland, DO;Louis P. Voigt, MD;Yesne Alici, MD

November 24th 2025

How to Mitigate the Emotional, Logistical, and Financial Burdens of Cancer Treatment?

Daniel C. McFarland, DO, is joined by Louis P. Voigt, MD, and Yesne Alici, MD, who focused on decision-making capacity and patient-centered care.

According to Rachel Greenup, MD, MPH, some of the barriers to getting optimal treatment for breast cancer include access, insurance, and baseline understanding or knowledge.

Tim Cortese

According to Rachel Greenup, MD, MPH, some of the barriers to getting optimal treatment for breast cancer include access, insurance, and baseline understanding or knowledge.

HRQOL Finds Similar Responses Between Surgery/Treatment Options in NMIBC

ONCOLOGY Editorial Advisory Board Member Dies from Glioblastoma

HRQOL scores were similar among patients who received a radical cystectomy or bladder persevering therapy for non-muscle invasive bladder cancer.

Related Content

Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center

Edward Chu, MD, a member of the gastrointestinal editorial advisory board, died of glioblastoma in November.

Girindra Raval, MD;Amany Keruakous, MD;Daniel Peters, MD

Subcutaneous Toripalimab Meets Primary End Points in Nonsquamous NSCLC

Experts from Georgia Cancer Center highlight ongoing retrospective studies, translational research, and other initiatives across different cancers.

Roman Fabbricatore

November 30th 2025

Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

The developers plan to submit a new drug application to regulatory authorities for JS001sc for the treatment of first-line nonsquamous NSCLC.

Daniel C. McFarland, DO;Louis P. Voigt, MD;Yesne Alici, MD

November 24th 2025

How to Mitigate the Emotional, Logistical, and Financial Burdens of Cancer Treatment?

Daniel C. McFarland, DO, is joined by Louis P. Voigt, MD, and Yesne Alici, MD, who focused on decision-making capacity and patient-centered care.

Tim Cortese

According to Rachel Greenup, MD, MPH, some of the barriers to getting optimal treatment for breast cancer include access, insurance, and baseline understanding or knowledge.